非抗凝血剂肝素:对口腔癌的新疗法进行体外研究
S A Hamza1, R Paolini1, N M O'Brien-Simpson1
1Faculty of Medicine, Dentistry and Health Sciences, Melbourne Dental School, Carlton, Victoria, Australia.
Oral diseases
|March 4, 2025
概括
非抗凝剂的氨酸 (NH) 通过抑制癌细胞的生长和迁移,在治疗口腔状细胞癌 (OSCC) 中表现有前途. NH还维持了标准化疗药物的疗效,这表明了OSCC的潜在新治疗途径.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 口腔状细胞癌 (OSCC) 是一个主要的全球健康问题.
- 抗凝药已显示在癌症患者的生存率有所改善.
- 非抗凝剂的氨酸 (NH) 正在作为OSCC的潜在治疗剂进行研究.
研究的目的:
- 评估非抗凝血剂肝素 (NH) 和肝素对口腔癌细胞系的体外影响.
- 评估NH和肝素对癌细胞增殖,迁移和入侵的影响.
- 为了确定NH和肝素是否会干扰用于OSCC的常见化疗剂的疗效.
主要方法:
- 进行了包括MTS,scratch,入侵Matrigel和细胞毒性测试在内的体外测试.
- 三个口腔人类细胞系 (H400/H357/OKF6) 接受了不同度的NH和肝素的治疗.
- 研究了NH和肝素与5FU和西斯普拉丁化疗剂的相互作用.
主要成果:
- NH在80U/mL的OSCC细胞系中表现出显著的细胞毒性和增殖抑制,与肝素相当.
- 无论是NH还是肝素都没有对正常的口腔细胞表现出细胞毒性作用.
- 和肝素都有效地抑制了癌细胞的迁移和入侵,并没有影响5FU和西斯的疗效.
结论:
- 非抗凝剂的氨酸 (NH) 显示出作为OSCC的抗癌剂的显著潜力.
- NH不会干扰OSCC标准化疗剂的疗效.
- 需要进一步的研究,包括临床前动物模型,以转化这些发现.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
590
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
590
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K


